Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome

NCT04734678 · clinicaltrials.gov ↗

COMPLETED

Status

153

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Cytokine Storm
Corona Virus Infection

Interventions

DRUG: Tocilizumab
DRUG: Infliximab

Sponsor

Ain Shams University

Collaborators

[object Object]